USD 450

Product Type

Industry Statistics

Release Date

15 March 2021


Asia Pacific

Release Year


Table of Contents
    Add a header to begin generating the table of contents


    The oncology drug market in China in terms of revenue is set to grow by US$ 42 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 13.8% during the forecast period, according to data and analytics company StrategyHelix.

    The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for oncology drug. The China oncology drug market is segmented on the basis of type, product. By type, it is categorized into Breast, Colorectum, Liver, Lung cancer, Stomach, Thyroid, and others. By product, the oncology drug market is divided into chemotherapy drugs, immunotherapy drugs, and targeted drugs. In 2020, the chemotherapy drugs segment held the largest share of the market, and the immunotherapy drugs segment is anticipated to register the highest CAGR during 2021-2027.

    The report has profiled some of the key players of the market such as AstraZeneca plc., Bristol-Myers Squibb Company, Eli Lilly and Company, Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd., Novartis International AG, Roche Holding AG, Sanofi S.A., Taiho Pharmaceutical Co. Ltd..

    The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the oncology drug market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

    Report Scope

    Type: Breast, Colorectum, Liver, Lung cancer, Stomach, Thyroid, and others
    Product: chemotherapy drugs, immunotherapy drugs, and targeted drugs
    Years Considered: this report covers the period 2017 to 2027

    Key Benefits for Stakeholders

    Get a comprehensive picture of the China oncology drug market
    Pinpoint growth sectors and trends for investment
    Understand what the future of the oncology drug market in China looks like
    Identify the competitive landscape and window of opportunity

    Table of Contents

    1. Market Definition
    2. Research Methodology
    3. Market Data & Outlook
    3.1 Market Value
    3.2 Market Value Forecast
    4. Oncology Drug Market by Type
    4.1 Breast
    4.2 Colorectum
    4.3 Liver
    4.4 Lung Cancer
    4.5 Stomach
    4.6 Thyroid
    4.7 Others
    5. Oncology Drug Market by Product
    5.1 Chemotherapy Drugs
    5.2 Immunotherapy Drugs
    5.3 Targeted Drugs
    6. Company Profiles
    6.1 AstraZeneca plc.
    6.2 Bristol-Myers Squibb Company
    6.3 Eli Lilly and Company
    6.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
    6.5 Novartis International AG
    6.6 Roche Holding AG
    6.7 Sanofi S.A.
    6.8 Taiho Pharmaceutical Co., Ltd.
    7. Appendix
    7.1 About StrategyHelix
    7.2 Disclaimer

    StrategyHelix Black LOGO


    Please fill out our form and we will get back to you.

    Oncology Drug Market in China 2021

    StrategyHelix Black LOGO


    Custom projects can be researched to match your unique needs.

    Oncology Drug Market in China 2021